Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles
Gianna T. Busch, Ryan H. Boe, Jingxin Li, Robert F. Gruener, Miles J. Arnett, Pavithran T. Ravindran, Meenhard Herlyn, R. Stephanie Huang, Arjun Raj
The paper shows that therapy-resistant cancer cell clones have distinct drug sensitivity profiles, and combinations targeting these subpopulations can effectively eliminate resistant populations.
bioRxiv · Apr 25, 2025 · PreprintSystems Biology